false
0000802257
0000802257
2026-10-05
2026-10-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d)
of
the Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported): October 5, 2026
MITESCO,
INC.
(Exact
Name of Registrant as Specified in Charter)
| Nevada |
|
000-53601 |
|
87-0496850 |
(State
or another jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer
Identification No.) |
505
Beachland Blvd., Suite 1377
Vero Beach, Florida 32963
(Address
of principal executive offices) (Zip Code)
(844)
383-8689
(Registrant’s
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act: None
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| N/A |
|
N/A |
|
N/A |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01 Entry into a Material Definitive Agreement.
On October
5, 2026 Mitesco, Inc. (the “Company”)
received funding from a historical investor in the Company from a new 2026 Bridge Notes. The 10% Original Issue Discount Convertible
Promissory Note (the “2026
Bridge Note”) with ZSP Capital, LLC. whose note has a face of $25,000. The note bears interest of 10% and has a maturity 12 months
from the date of the note. Under the terms of the notes, the Company is obligated to repay a total of $27,500 as the note includes a 10%
original issue discount. The notes may be converted into common stock of the Company at $0.15 per share, subject to certain adjustments.
The description of the 2026 Bridge Note and related Securities Purchase Agreement represents summaries and are qualified in their entirety
by Exhibit 10.1 and Exhibit 10.2, attached hereto and incorporated herein by reference.
The form of note and securities purchase agreement is attached to this
report as Exhibit 10.1 and 10.2.
Item 3.02 Unregistered Sales of Equity Securities.
The Company has issued 500,000 shares of restricted common stock to
each of two (2) individuals as compensation for assistance with its TCDC edge computing network data center project. The shares were valued
at $0.0375 each and will record a charge of $18,750 for each of the issuances.
The Company has issued 500,000 shares of restricted common stock to
each of two (2) individuals as compensation for assistance with its Robo Agent application software project. The shares were valued at
$0.0375 each and will record a charge of $18,750 for each of the issuances.
The securities described have
not been registered under the Securities Act of 1933 and may not be offered or sold in the United States absent registration or an applicable
exemption from the registration requirements. The securities where issued pursuant to an exemption from registration under Section 4(a)(2)
of the Securities Act of 1933 as amended.
As a result of these issuances there are approximately 51 million shares
of common stock issued and outstanding as of the date of this filing..
Item 5.02 Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On October 8, 2026 the Company received the resignation
of Dr. Jordan Ballencic from the Board of Directors. Dr. Ballencic cited a lack of available time to meet the responsibilities of the
role as a Director of the Company as his reason for leaving. The Company has no conflicts with Dr. Ballencic and thanks him for his time
on the Board. A copy of his resignation letter is attached to this filing in Exhibit 10.1.
Given the previously announced acquisition efforts
the Board does not intend to fill the opening on the Board created as a result of Dr. Ballencic’s resignation.
Item 8.01 Other Events.
The Company continues discussions with a number
of acquisition candidates and the restructuring of its Bridge notes and Series A Preferred shares.
Item 9.01 Financial Statements and Exhibits
| Exhibit No. |
|
Description |
| 10.1 |
|
Resignation
letter from Dr. Jordan Balencic |
| 10.2 |
|
Form
of 2026 Bridge Note from ZSP Capital, LLC |
| 10.3 |
|
Form
of 2026 Bridhe Note Securities Purchase Agreement from ZSP Capital, LLC |
| 104 |
|
Cover
Page Interactive Data File (formatted as Inline XBRL) |
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Dated: October 13, 2026 |
MITESCO, INC. |
| |
|
|
| |
By: |
/s/ Mack Leath |
| |
|
Mack Leath |
| |
|
Chairman and CEO |
